This study investigates how unfractionated heparin (UFH) modulates interactions between the SARS-CoV-2 spike protein (S protein) and platelet factor 4 (PF4). Given prior proposals that PF4 may form complexes with the viral spike and potentially contribute to immune-mediated thrombotic complications, the authors applied complementary biochemical, single-molecule, and computational techniques to characterize binding and mechanistic effects. The work focuses on concentration-dependent behavior of UFH and uses a dp5 heparin fragment in molecular dynamics simulations to probe molecular-level interactions.
The authors combined three principal approaches:
Ensemble binding assays (ELISA) to quantify how UFH alters interactions between S protein and its partners, including ACE2 and PF4.
Single-molecule force spectroscopy to measure mechanical stability and unbinding forces of PF4–S protein complexes in the presence of varying UFH concentrations.
Molecular dynamics simulations employing a dp5 heparin fragment to examine energetics, contact patterns, and conformational effects when heparin, PF4, and the S1 subunit form ternary assemblies.
The abstract reports results from these complementary techniques to derive mechanistic insight into how glycosaminoglycan binding modulates protein–protein interactions at a viral–host interface.
ELISA measurements revealed that UFH has biphasic effects on ACE2 engagement with the S protein. Specifically, low concentrations of UFH enhanced ACE2–S protein binding, while higher concentrations produced a modest reduction in ACE2 interaction. The observation indicates that UFH does not act solely as a competitive inhibitor of receptor binding but instead exerts concentration-dependent modulation of the spike–receptor interface.
The influence of UFH on PF4–S protein binding differed from its effect on ACE2. According to ELISA results reported in the abstract, UFH inhibited PF4–S protein binding at low to intermediate concentrations, with partial restoration of binding at higher UFH concentrations. This partner-specific and concentration-dependent pattern suggests distinct modes of interaction when PF4 is involved compared with ACE2, and indicates that heparin can both disrupt and, under some conditions, permit PF4–S protein association depending on concentration.
Single-molecule force spectroscopy experiments corroborated the inhibitory effect of UFH on the PF4–S protein complex by demonstrating decreased mechanical stability in the presence of heparin. The measured unbinding forces for the PF4–S protein complex were reduced with UFH and reached a saturation point at concentrations ≥5 IU mL–1. These biophysical data show that heparin reduces the force required to disrupt PF4–S protein bonds, consistent with weakened or remodeled interfacial contacts in the ternary context.
Molecular dynamics simulations using a dp5 heparin fragment indicated energetically favorable binding to both PF4 and the S1 subunit of the spike protein. In simulated ternary assemblies (S1–PF4–dp5), heparin changed interfacial contacts and altered the energetic landscape of the PF4–S1 interaction. The computational results support a model in which heparin associates with both partners and induces conformational and electrostatic changes at the protein–protein interface rather than acting solely through steric exclusion.
Taken together, the ensemble binding data, single-molecule force measurements, and simulations support a mechanism in which heparin modulates PF4–S protein complexes via electrostatic reorganization and interfacial remodeling. Heparin’s multivalent and highly sulfated character enables it to bind favorably to charged patches on PF4 and the S1 subunit, reshaping contacts and the energetic profile of the complex. The concentration dependence—enhancement of ACE2 binding at low heparin concentrations but modest reduction at higher levels, and inhibition of PF4 binding at low-to-intermediate heparin with partial recovery at high concentrations—indicates that net effects depend on stoichiometry and local interface geometry.
The findings provide mechanistic insight into how glycosaminoglycans can regulate PF4–S protein complexes, with implications for understanding immune–thrombotic phenomena linked to SARS-CoV-2. Specifically, the data indicate that UFH can weaken PF4–S protein mechanical stability and remodel interfacial contacts in a concentration-dependent manner. These mechanistic observations may inform further research into the role of PF4–spike complexes in pathophysiology and how therapeutic or prophylactic use of heparin influences viral–host protein interactions.
Limitations and further details beyond what is summarized in the abstract (for example, exact concentrations tested, quantitative ELISA values, force spectroscopy force distributions, and full simulation parameters) were not reported in the provided source text and would require consultation of the full article for comprehensive appraisal.